BioPharm News

Oct 16, 2017
By BioPharm International Editors
Through the support of the Japanese agency, Daiichi Sankyo intends to further develop its genetic vaccine platform focused around its new nucleic acid delivery technology.
Oct 16, 2017
By BioPharm International Editors
The new center will serve as a regional hub where scientists and engineers can work with customers for biological development.
Oct 16, 2017
By BioPharm International Editors
Stelara (ustekinumab), already approved for treating adults, is now also approved for treating adolescents with moderate to severe plaque psoriasis.
Oct 16, 2017
By BioPharm International Editors
The companies will collaborate to produce and improve the recombinant properties of Aethlon’s Hemopurifier blood purification device.
Oct 16, 2017
By BioPharm International Editors
The vaccine is a non-live, recombinant subunit vaccine that combines an antigen and an adjuvant system to trigger a targeted and long-lasting immune response to the shingle-causing virus.
Oct 14, 2017
By BioPharm International Editors
Samsung BioLogics’ second facility adds 152,000 L of mAb drug substance capacity.
Oct 13, 2017
By BioPharm International Editors
The committee has voted unanimously to approve Spark Therapeutics’ gene therapy candidate, Luxturna (voretigene neparvovec), for treating a genetically inherited blindness.
Oct 13, 2017
By BioPharm International Editors
Baxter and FDA are working together to prevent shortages of the company’s sodium chloride 0.9% injection bags after recent hurricanes damaged the island.
Oct 12, 2017
By BioPharm International Editors
The collaboration will focus on developing a novel and differentiated challenge model for respiratory syncytial virus.
Oct 12, 2017
By BioPharm International Editors
NIH has entered a five-year, $215-million collaboration with leading biopharmaceutical companies to advance the development of cancer immunotherapies.
native1_300x100
lorem ipsum